{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:55:00Z","timestamp":1753876500529,"version":"3.41.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.1093\/europace\/euad338","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T03:40:33Z","timestamp":1699674033000},"source":"Crossref","is-referenced-by-count":1,"title":["Time to consider catheter ablation as an alternative to implantable cardioverter-defibrillator therapy in high-risk patients with Brugada syndrome?"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-3456","authenticated-orcid":false,"given":"Giulio","family":"Conte","sequence":"first","affiliation":[{"name":"Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale , Via Tesserete 48 , Lugano CH-6900, Switzerland"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana, Lugano, Switzerland (USI)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-8619","authenticated-orcid":false,"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, L'institut du thorax, CHU Nantes , Nantes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"2023122114274390500_euad338-B1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B2","first-page":"665","article-title":"J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"19","author":"Antzelevitch","year":"2017","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B3","doi-asserted-by":"crossref","first-page":"euad180","DOI":"10.1093\/europace\/euad180","article-title":"From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies","volume":"25","author":"Crotti","year":"2023","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B4","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2023122114274390500_euad338-B5","doi-asserted-by":"crossref","first-page":"euad318","DOI":"10.1093\/europace\/euad318","article-title":"Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an ICD implantation","author":"Li","year":"2023","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jacep.2018.10.007","article-title":"Challenge and impact of quinidine access in sudden death syndromes: a national experience","volume":"5","author":"Malhi","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2023122114274390500_euad338-B7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023122114274390500_euad338-B8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023122114274390500_euad338-B9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023122114274390500_euad338-B10","doi-asserted-by":"crossref","first-page":"euad112","DOI":"10.1093\/europace\/euad112","article-title":"Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study","volume":"25","author":"Jespersen","year":"2023","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B11","doi-asserted-by":"crossref","first-page":"euad205","DOI":"10.1093\/europace\/euad205","article-title":"Patient-reported outcome measures on mental health and psychosocial factors in patients with Brugada syndrome","volume":"25","author":"Six","year":"2023","journal-title":"Europace"},{"key":"2023122114274390500_euad338-B12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023122114274390500_euad338-B13","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023122114274390500_euad338-B14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Ha\u00efssaguerre","year":"2003","journal-title":"Circulation"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euad338\/53176633\/euad338.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/12\/euad338\/54693528\/euad338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/12\/euad338\/54693528\/euad338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:28:42Z","timestamp":1703168922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad338\/7394834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad338","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"type":"print","value":"1099-5129"},{"type":"electronic","value":"1532-2092"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,11,9]]},"article-number":"euad338"}}